• 

  Amyloid Hypothesis in the Hot Seat After Aduhelm Approved for Alzheimer’s
• 

  What is an Aduhelm Infusion, and Why Was Its Approval So Controversial?
• 

  What Is Aduhelm and How Does It Fight Alzheimer’s?
• 

  Phil’s Journal: Aduhelm Is Greenlit to Treat Alzheimer’s—It’s Still Complicated
• 

  Q&A: Dr. Eric Larson on Ways to Lower Dementia Risk—and Why They Work
• 

  Experts Respond to Aduhelm Approval
• 

  Aducanumab Approved: U.S. FDA Gives Biogen Alzheimer’s Drug Approval
• 

  “This Is How I’m Living Life:” Perspectives on Dementia
• 

  Our Experience With Aduhelm: Inside the Clinical Trial
• 

  Phil’s Journal: What’s Next for the Aducanumab Clinical Trial Rollercoaster?
• 

  Zooming Their Way to Better Brain Health: Can Video Chats Slow Dementia?
• 

  ‘A Viral Video of My Grandparents,’ Robots for the Lonely, and Other May Reads
• 

  Alzheimer’s Drugs Worth Repurposing?
• 

  Detecting and Treating Alzheimer’s Before Symptoms Set In, With Dr. Jason Karlawish
• 

  Neurologist Q&A: The Transformative Power of Art in Dementia Care

Previous818283Next